Industries > Pharma > Global Influenza Vaccines Market Outlook 2018-2028

Global Influenza Vaccines Market Outlook 2018-2028

Forecasts for Trivalent Influenza Vaccines (TIV) & Quadrivalent Influenza Vaccines (QIV), Revenue Forecasts and Analysis of Pipeline Developments for Fluzone / VaxiGrip, Seqirus, Fluarix / FluLaval, FluMist / Fluenz, FluBlok and Other

PUBLISHED: 19 June 2018
PAGES: 138
PRODUCT CODE: PHA0318
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE
SKU: PHA0318 Categories: , Tags: , , , ,

The latest report from business intelligence provider visiongain offers comprehensive analysis of the global influenza vaccines market. Visiongain assesses that this market will generate revenues of $3.5 billion in 2018.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector. Visiongain’s new study tells you and tells you NOW.

In this brand new 138-page report you find 63 in-depth tables, charts and graphs – all unavailable elsewhere.

The report provides clear detailed insight into the global Influenza market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope
Visiongain’s new investigation shows revenue predictions at overall world market, submarket, company, product and national level.

That study gives individual analysis for two influenza vaccine submarkets, which are further divided by vaccine technologies:
• Trivalent Influenza Vaccines (TIV)
• Quadrivalent Influenza Vaccines (QIV)

Our new analysis also shows you revenue predictions for the vaccines produced by these five market leaders: and their market share:
• Sanofi Pasteur
• GSK
• Seqirus
• AstraZeneca
• Protein Science Corporation.
• Others

From 2018, large pharmaceutical companies and other biopharma specialists can prosper in that market. See how, discovering organisations’ potentials.

Our report analyses the vaccines in research and development and assess their prospects once they enter the market. The R&D pipeline discusses:
• Seasonal Influenza vaccines in development
• Universal Influenza vaccines in development

The report includes forecasts to 2028 and analysis of pipeline developments for the following specific vaccines:
• Fluzone / VaxiGrip
• Seqirus
• Fluarix / FluLaval
• FluMist / Fluenz
• FluBlok
• Other

The study shows you prospects for those drug sales in developed and developing regions. There see individual revenue forecasts to 2028 for 11 countries:
• United States
• Japan
• The EU 5 – Germany, France, United Kingdom, Italy and Spain.
• Brazil, Russia, India and China

Global Influenza Vaccines Market Outlook 2018-2028

Who should read this report?
• Anyone within the influenza vaccines value chain.
• Pharmaceutical companies
• Vaccine manufacturers
• Healthcare biotech companies
• Generics and biosimilar producers
• Drug delivery companies and other technology providers
• Contract/clinical research organisations (CROs)
• Pharma contract manufacturers,
• Pharma/healthcare wholesale and distribution companies
• Medical device companies
• Healthcare diagnostics companies
• R&D specialists
• Business development managers
• Marketing managers
• Technologists
• Suppliers
• Investors
• Banks
• Government agencies
• Contractors

Visiongain’s study is intended for anyone requiring commercial analyses for the influenza vaccines market and leading companies. You find data, trends and predictions.

Buy our report today Global Influenza Vaccines Market Outlook 2018-2028: Forecasts for Trivalent Influenza Vaccines (TIV) & Quadrivalent Influenza Vaccines (QIV), Revenue Forecasts and Analysis of Pipeline Developments for Fluzone / VaxiGrip, Seqirus, Fluarix / FluLaval, FluMist / Fluenz, FluBlok and Other. Avoid missing out by staying informed – get our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Influenza Vaccines Market Outlook 2018-2028


Download sample pages

Complete the form below to download your free sample pages for Global Influenza Vaccines Market Outlook 2018-2028


Latest Pharma news

“Global ophthalmic packaging market will grow at a CAGR over 5% by 2030”, says Visiongain

Visiongain’s new report the Ophthalmic Packaging Market Report 2020-2030: Forecasts by Dose (single dose, multiple dose), by Type (OTC and prescription) by Material (Glass, plastic, and others) plus analysis of leading companies indicates that the global ophthalmic packaging market will grow at a CAGR over 5% by 2030. The main factors driving demand are the increasing prevalence of eye disorders, …

23 January 2020

READ

“Global ophthalmology PCAS market will grow at a CAGR over 5% by 2030”, says Visiongain

Visiongain’s new report the Ophthalmology PCAS Market Report 2020-2030: Forecasts by Type (stand alone and integrated), by Delivery Mode (cloud based and on premises) by End Use (Hospitals and Specialty Clinics) plus analysis of leading companies indicates that the global ophthalmology PCAS market will grow at a CAGR over 5% by 2030. Increasing the use of teleophthalmology solutions due to …

23 January 2020

READ

“Global Oncology Information Systems market will cross 3.0 billion revenues by 2030”, says Visiongain

Visiongain’s new report the Oncology Information Systems Market Report 2020-2030: Forecasts by Product (Software, Professional Services), by Application (Medical Oncology, Radiation Oncology, Surgical Oncology) plus analysis of leading companies indicates that the global Oncology Information Systems market will cross 3.0 billion revenues by 2030. The global Oncology Information Systems market is likely to cross USD 3.0 billion by 2030 at …

23 January 2020

READ

“Global oncology companion diagnostics market will cross 1.0 Bn revenue by 2030”, says Visiongain

Visiongain’s new report the Oncology Companion Diagnostics Market Forecast 2020-2030: Forecasts by Product (Assays, Kits, & Reagents, Software & Technology) By Technology (Polymerase Chain Reaction, In Situ Hybridization, Immunochemistry, Others),by End use (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations, Others) plus analysis of leading companies indicates that the global oncology companion diagnostics market will cross 1.0 billion revenue …

23 January 2020

READ

Categories

Category